While Congress is in Recess…
Although Congress is in recess this week, there are still important ways in which you can advocate for passage of the Lymphedema Treatment Act! There are many lymphedema patients who are frustrated by
Although Congress is in recess this week, there are still important ways in which you can advocate for passage of the Lymphedema Treatment Act! There are many lymphedema patients who are frustrated by
When we conducted our first survey two months ago the pandemic was just beginning. We’ve since seen that this virus can manifest in a wide range of symptoms, with a
The House is expected to return this week to vote on the next legislative package – please contact your Representative again about including the LTA! Calling is the most effective and all
The Senate is back in session and needs to hear from you! If you have not called and emailed your Senators recently please do so this week. Calling is the most effective and
Congressional leadership has given member offices a deadline of the end of this week for submission of priorities for the next legislative package! That’s not to say that anything will
Congress is beginning to work on the next COVID-19 response package, and it is expected to have a broader focus than previous coronavirus-related legislation. Please contact your members of Congress and ask them
Ever wonder what the history of the Lymphedema Treatment Act is? What follows is a brief overview told from the perspective of my family. I hope you will be inspired
Thank you to all those who participated in our recent survey, What is the Impact of COVID-19 on Lymphedema Patients? The responses made it clear that the impact this crisis is having
We are continuing to keep in close contact with our bill sponsors and other key congressional offices, vigilantly watching for any possible opportunity to include the LTA in one of
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

